Diagnostics and research stocks cheapest against their own PE history

Ranked

15

of 74 diagnostics and research stocks we cover

Median

65th pct

Lowest

3rd pct

IDXX

Range

3rd pct to 100th pct

#	Company	PE vs its 10 years	PE	Its 10y median PE	Market cap
1	IDXXIDEXX Laboratories	3rd pct	39.4×	55.0×	$44.1B
2	ILMNIllumina	48th pct	50.1×	51.4×	$40.7B
3	IQVIQVIA	49th pct	34.7×	34.9×	$46B
4	LNTHLantheus	52nd pct	24.2×	24.0×	$6.5B
5	MTDMettler-Toledo International	55th pct	37.6×	36.5×	$33.5B
6	BIOBio-Rad Laboratories	56th pct	44.8×	30.8×	$9.9B
7	AAgilent Technologies	58th pct	34.0×	33.1×	$48.8B
8	TMOThermo Fisher Scientific	65th pct	35.5×	33.0×	$249.1B
9	LHLabcorp	73rd pct	27.2×	19.4×	$26.7B
10	DHRDanaher	82nd pct	40.9×	34.2×	$162B
11	ICCCImmucell	87th pct	128×	44.0×	$93.1M
12	RVTYRevvity	93rd pct	75.6×	34.8×	$17.7B
13	WATWaters	94th pct	113×	29.2×	$44.6B
14	DGXQuest Diagnostics	99th pct	25.7×	19.3×	$26.7B
15	NRCNRC Health	100th pct	87.7×	35.1×	$485.1M

Not ranked: 51 with no PE (losses over the last year), 3 with under ten years of history. 5 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.